Cabaletta Bio (CABA) Share-based Compensation (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26.78% |
| Sep 30, 2025 | 1.93% |
| Jun 30, 2025 | 10.54% |
| Mar 31, 2025 | -4.62% |
| Dec 31, 2024 | 118.10% |
| Sep 30, 2024 | -4.43% |
| Jun 30, 2024 | -31.52% |
| Mar 31, 2024 | 24.25% |
| Dec 31, 2023 | 191,065.41% |
| Sep 30, 2023 | 14.66% |
| Jun 30, 2023 | -99.94% |
| Mar 31, 2023 | 57.16% |
| Dec 31, 2022 | -8.84% |
| Sep 30, 2022 | 101.98% |
| Jun 30, 2022 | -52.68% |
| Mar 31, 2022 | 13.12% |
| Dec 31, 2021 | 134.41% |
| Sep 30, 2021 | -0.15% |
| Jun 30, 2021 | -47.79% |
| Mar 31, 2021 | -0.83% |
| Dec 31, 2020 | 124.66% |
| Sep 30, 2020 | 19.76% |
| Jun 30, 2020 | -43.76% |
| Mar 31, 2020 | 6.59% |
| Dec 31, 2019 | 1,761.36% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | -91.13% |
| Mar 31, 2019 | 77.14% |
| Dec 31, 2018 | 43.59% |